FLNB
protein-codingfilamin B, the group of Filamins
Gene summary
This gene encodes a member of the filamin family. The encoded protein interacts with glycoprotein Ib alpha as part of the process to repair vascular injuries. The platelet glycoprotein Ib complex includes glycoprotein Ib alpha, and it binds the actin cytoskeleton. Mutations in this gene have been found in several conditions: atelosteogenesis type 1 and type 3; boomerang dysplasia; autosomal dominant Larsen syndrome; and spondylocarpotarsal synostosis syndrome. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Nov 2009]
- FLN1L
- LRS1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~163.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007168
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007875
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010094
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007208
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007167
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0019690
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010094
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0010094
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010094
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:1060173
Submitter: ClinGen
Filamin B (FLNB; MIM#603381) is a large dimeric actin binding protein and multi-functional signaling scaffold with roles in crosslinking actin cytoskeleton filaments, and signaling through interactions with a variety of receptors, signaling molecules, and transcription factors. FLNB is associated with both autosomal dominant and autosomal recessive disease entities with opposing mechanisms of disease. Given the difference in inheritance pattern and disease mechanism, the Prenatal Gene Curation Expert Panel has split these two disease entities into FLNB-associated autosomal dominant filamin related bone disorder(MONDO:1060173) and Spondylocarpotarsal Synostosis Syndrome (MONDO:0010094), inherited in an autosomal recessive pattern. These have been curated separately. Heterozygous variants in the FLNB gene were first reported in relation to a skeletal dysplasia in Krakow, et.al. 2004 [PMID:14991055] and since have been reported in many affected individuals with a wide phenotypic spectrum ranging from pre- or perinatal lethal skeletal dysplasia historically referred to as Boomerang Dysplasia to a milder form with survival to adulthood often referred to as Larsen syndrome, as well as intermediate phenotypes Atelosteogenesis Type I and Atelosteogenesis Type III. The Prenatal Gene Curation Expert Panel has found no evidence of different inheritance patterns or disease mechanism between these entities, with several recurrent variants or variants at the same amino acid associated with variable phenotypic presentations and severity (p.Met202, p.Gly1691Ser, p.Trp189Arg). Given this, the Prenatal Gene Curation Expert Panel has lumped these into a single disease entity, FLNB-associated autosomal dominant filamin related bone disorder (MONDO:1060173). Prenatal phenotypes are highly variable and include prenatal or perinatal lethality, hydrops or cystic hygroma, phocomelia, micromelia or absent bones of the limbs in the severe form of disease; and short limb dwarfism, club feet, polyhydramnios, congenital joint dislocations, fetal growth restriction, and dysmorphic features including micrognathia, cleft palate, hypertelorism and hypoplastic vertebrae in more mild presentations. Maximum genetic evidence was reached with both recurrent and non-recurrent variants, often identified de novo in affected individuals or inherited from variably affected parents [PMID:16752402, 2219045, 16801345, 19085972, 14991055, 22354125, others]. Genetic evidence is supported by functional evidence including protein-protein interactions, expression studies, and functional alterations demonstrating focal accumulations of FLNB with actin [PMID:11807098, 28175289, 17360453, 17635842, 17510210, 14991055, 22190451]. The mechanism of disease is proposed to be gain-of-function or dominant negative, and while missense and in-frame indel variants associated with milder phenotypic manifestations are found throughout the protein, variants found in the CH2 domain are more commonly associated with phenotypes on the more severe end of the spectrum [PMID:22190451]. In summary the Prenatal Gene Curation Expert Panel has found sufficient genetic and functional evidence to classify FLNB as DEFINITIVE for FLNB-associated autosomal dominant filamin related bone disorder (Gene-Disease Validity SOPv11).
Inheritance Pattern: AD
Disease ID:MONDO:0007168
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007875
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007875
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007167
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007167
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal
Intervention: Audiologic/Otolaryngologic; Musculoskeletal
Rationale: Surveillance and early intervention related to cervical spine stability can allow early detection and treatment of manifestations; Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FLNB variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001457.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 22 | 582 | 9 | 613 | ||
| missense | 20 | 41 | 1150 | 328 | 17 | 1556 |
| nonsense | 23 | 11 | 3 | 37 | ||
| start loss | 0 | |||||
| frameshift | 31 | 18 | 3 | 52 | ||
| splice donor/acceptor (+/-2bp) | 3 | 26 | 19 | 48 | ||
| Total | 77 | 96 | 1197 | 910 | 26 | 2306 |
Highest pathogenic variant AF is 0.00026150807
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001448.2 | 46 | MANE Select | |
| Ensembl | ENSP00000295956.5 | 46 | MANE Select | |
| RefSeq | NP_001157789.1 | 47 | Standard | |
| RefSeq | NP_001157790.1 | 46 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Focal adhesion - Homo sapiens (human)
- Salmonella infection - Homo sapiens (human)
- MAPK signaling pathway - Homo sapiens (human)
- Proteoglycans in cancer - Homo sapiens (human)
- Focal Adhesion
Biological Process
- keratinocyte development
- epithelial cell morphogenesis
- cytoskeletal anchoring at plasma membrane
- signal transduction
- skeletal muscle tissue development
Molecular Function
- RNA binding
- actin binding
- protein binding
- identical protein binding
- cadherin binding
Cellular Component
- stress fiber
- cytoplasm
- cytosol
- plasma membrane
- brush border
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000490882
- Coding exons
- 47
- Length
- 163856
- Individuals with no LoFs
- 125628
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 120
- Defined
- 125748
- p
- 0.000477
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.14 | 1326 | 1.56e+3 | 0.848 | 0.0000973 | 17224 |
| Missense (PolyPhen) | 553 | 773.42 | 0.71501 | 8482 | ||
| Synonymous | -0.129 | 666 | 662 | 1.01 | 0.0000486 | 5349 |
| Loss of Function | 6.50 | 38 | 112 | 0.338 | 0.00000586 | 1356 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00032 | 0.00032 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.0011 | 0.0011 | notable |
| Finnish | 0.00032 | 0.00032 | rare |
| European (Non-Finnish) | 0.00050 | 0.00049 | rare |
| South Asian | 0.00052 | 0.00052 | rare |
| Other | 0.00082 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Connects cell membrane constituents to the actin cytoskeleton. May promote orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Various interactions and localizations of isoforms affect myotube morphology and myogenesis. Isoform 6 accelerates muscle differentiation in vitro.;
- Disease
- DISEASE: Note=Interaction with FLNA may compensate for dysfunctional FLNA homodimer in the periventricular nodular heterotopia (PVNH) disorder.; DISEASE: Atelosteogenesis 1 (AO1) [MIM:108720]: A lethal chondrodysplasia characterized by distal hypoplasia of the humeri and femurs, hypoplasia of the mid-thoracic spine, occasionally complete lack of ossification of single hand bones, and the finding in cartilage of multiple degenerated chondrocytes which are encapsulated in fibrous tissue. {ECO:0000269|PubMed:14991055}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atelosteogenesis 3 (AO3) [MIM:108721]: A short-limb lethal skeletal dysplasia with vertebral abnormalities, disharmonious skeletal maturation, poorly modeled long bones and joint dislocations. Recurrent respiratory insufficiency and/or infections usually result in early death. {ECO:0000269|PubMed:14991055}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Boomerang dysplasia (BOOMD) [MIM:112310]: A perinatal lethal osteochondrodysplasia characterized by absence or underossification of the limb bones and vertebrae. Patients manifest dwarfism with short, bowed, rigid limbs and characteristic facies. Boomerang dysplasia is distinguished from atelosteogenesis on the basis of a more severe defect in mineralization, with complete absence of ossification in some limb elements and vertebral segments. {ECO:0000269|PubMed:15994868}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Larsen syndrome (LRS) [MIM:150250]: An osteochondrodysplasia characterized by large-joint dislocations and characteristic craniofacial abnormalities. The cardinal features of the condition are dislocations of the hip, knee and elbow joints, with equinovarus or equinovalgus foot deformities. Spatula-shaped fingers, most marked in the thumb, are also present. Craniofacial anomalies include hypertelorism, prominence of the forehead, a depressed nasal bridge, and a flattened midface. Cleft palate and short stature are often associated features. Spinal anomalies include scoliosis and cervical kyphosis. Hearing loss is a well-recognized complication. {ECO:0000269|PubMed:14991055, ECO:0000269|PubMed:16801345}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondylocarpotarsal synostosis syndrome (SCT) [MIM:272460]: Disorder characterized by short stature and vertebral, carpal and tarsal fusions. {ECO:0000269|PubMed:14991055}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.216
Intolerance Scores
- LoFtool
- 0.00269
- RVIS EVS
- -1.44
- RVIS percentile EVS
- 3.94
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.917
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |